MYC Inhibition Plus P53 Stabilization Targets Leukemic Stem Cells

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-rw2016-114
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Virtual Drug Design: Skp1–Skp2 Inhibition Targets Cancer Stem Cells

Asian Journal of Andrology
MedicineUrology
2013English

Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells

Cancer Cell
Cancer ResearchOncologyCell Biology
2018English

Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells

Cancer Cell
Cancer ResearchOncologyCell Biology
2019English

Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation

Molecular Cancer Therapeutics
Cancer ResearchOncology
2017English

FoxO Proteins or Loss of Functional P53 Maintain Stemness of Glioblastoma Stem Cells and Survival After Ionizing Radiation Plus PI3K/mTOR Inhibition

Oncotarget
Oncology
2016English

Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms

Clinical Cancer Research
Cancer ResearchOncology
2015English

The Sorafenib Plus Nutlin-3 Combination Promotes Synergistic Cytotoxicity in Acute Myeloid Leukemic Cells Irrespectively of FLT3 and P53 Status

Haematologica
Hematology
2012English

Spindle Assembly Checkpoint Inhibition Can Resensitize P53-Null Stem Cells to Cancer Chemotherapy

Cancer Research
Cancer ResearchOncology
2019English

Resetting Cancer Stem Cell Regulatory Nodes Upon MYC Inhibition

EMBO Reports
BiochemistryGeneticsMolecular Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy